Posted by Michael Wonder on 05 Oct 2022
Continued development of the national health data registers leads to better follow-up of medicines
3 October 2022 - The Dental and Pharmaceutical Benefits Agency (TLV) is today handing over a report to the government on the importance of access to data for the follow-up of medicines.
Increased reporting of prescription drugs, a national primary care register and the possibility for TLV to handle individual data are three areas the authority highlights in the report.
